Chelation therapy for arteriosclerosis
Soffer, A.
JAMA 233(11): 1206-1207
1975
ISSN/ISBN: 0098-7484 PMID: 808649 Document Number: 90559
Chelation therapy for arteriosclerosis is reviewed. It is not recommended because there are no data from controlled trials that demonstrate its efficacy.
Document emailed within 1 workday
Related Documents
Geller, S.L. 1986: Questions on chelation therapy Journal of the Florida Medical Association 73(12): 921-922Godfrey, M.E.; Frackleton, J.P.; Chappell, L.T. 1994: Chelation therapy for intermittent claudication New Zealand Medical Journal 107(990): 495
Giardina, P.J.; Grady, R.W. 2001: Chelation therapy in beta-thalassemia: an optimistic update Seminars in Hematology 38(4): 360-366
O'Brien, S.F.; Kelly, S.E.; Dolphin, P.J.; Russell, J.C. 2000: Chelation therapy in the JCR:LA-cp rat: experimental assessment of a putative antiatherosclerotic treatment Clinical and Investigative Medicine 23(2): 124-131
Capra, L.; Atti, G.; De Sanctis, V.; Candini, G. 1983: Glucose tolerance and chelation therapy in patients with thalassaemia major Haematologica 68(1): 63-68
Margolis, S. 1995: Chelation therapy is ineffective for the treatment of peripheral vascular disease Alternative Therapies in Health and Medicine 1(2): 53-56
Chappell, L.T. 1995: EDTA chelation therapy should be more commonly used in the treatment of vascular disease Alternative Therapies in Health and Medicine 1(2): 53-57
Montgomery, M.R. 1986: Advances in medical fraud: chelation therapy replaces Laetrile Journal of the Florida Medical Association 73(9): 681-685
Rodríguez Galindo, C.; Ortega Aramburu, J.J.; Alonso, J.L.; Albisu, M.; Casaldáliga, J.; Díaz de Heredia, C.; Olivé, T.; Bastida, P. 1994: Evaluation of the efficacy of chelation therapy with deferoxamine in patients with thalassemia major Medicina Clinica 102(19): 721-724
Flora, S.J.S.; Mittal, M.; Mehta, A. 2008: Heavy metal induced oxidative stress and its possible reversal by chelation therapy Indian Journal of Medical Research 128(4): 501-523
Yver, L.; Maréchaud, R.; Picaud, D.; Touchard, G.; d'Eyzac, A.T.; Matuchansky, C.; Patte, D. 1978: Acute renal failure in the course of occupational lead intoxication. Chelation therapy responsability La Nouvelle Presse Medicale 7(18): 1541-1543
Victery, W.; Miller, C.R.; Goyer, R.A. 1986: Essential trace metal excretion from rats with lead exposure and during chelation therapy Journal of Laboratory and Clinical Medicine 107(2): 129-135
Tolis, G.; Politis, C.; Kontopoulou, I.; Poulatzas, N.; Rigas, G.; Saridakis, C.; Athanasiou, V.; Mortoglou, A.; Malachtari, S.; Ling, N. 1987: Pituitary somatotropic and corticotropic function in patients with beta-thalassemia on iron chelation therapy Birth Defects Original Article Series 23(5a): 449-452
Gordeuk, V.; Thuma, P.; Brittenham, G.; McLaren, C.; Parry, D.; Backenstose, A.; Biemba, G.; Msiska, R.; Holmes, L.; McKinley, E. 1992: Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria New England Journal of Medicine 327(21): 1473-1477
Platis, O.; Anagnostopoulos, G.; Farmaki, K.; Posantzis, M.; Gotsis, E.; Tolis, G. 2004: Glucose metabolism disorders improvement in patients with thalassaemia major after 24-36 months of intensive chelation therapy Pediatric Endocrinology Reviews: Per 2(Suppl 2): 279-281
Trenckman, H. 1978: Foundations of arteriosclerosis therapy Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 33(17): 625-628
Ahn, N.C.; Hancke, C. 1989: EDTA therapy of arteriosclerosis Ugeskrift for Laeger 151(40): 2599
Morozov, G.N. 1972: Oxygen therapy of arteriosclerosis Voenno-Meditsinskii Zhurnal 1: 36-38
Hinoara, S. 1970: Diet therapy for arteriosclerosis Nihon Rinsho. Japanese Journal of Clinical Medicine 28(5): 1488-1492
Van Vroonhoven, T.J.; de Smit, P. 1979: Anticoagulant therapy and peripheral arteriosclerosis Nederlands Tijdschrift Voor Geneeskunde 123(52): 226-229